Latest Quarter
2026-04-07
Jenscare Scientific Co Ltd (9877.HK)
Revenue
$6.7M
Net Income
-$84.8M
Operating Margin
-1,030.4%
Free Cash Flow
-$289M
Debt / Assets
10.8%
Values are in USD and rounded to the nearest whole number unless noted.
Swipe horizontally to view all columns.
| Income Statement (Quarterly) | 2026-04-07 | 2025-12-31 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
| Revenue | 6,713,000 | 75,873,677 | 6,713,000 | 0 |
| Cost of Revenue | 799,500 | 15,291,553 | 799,500 | 0 |
| Gross Profit | 5,913,500 | 60,582,124 | 5,913,500 | 0 |
| Operating Expenses | ||||
| R&D Expenses | 0 | 0 | 0 | 0 |
| SG&A Expenses | 30,638,500 | 52,692,976 | 30,638,500 | 0 |
| Operating Expenses | 75,081,000 | 149,786,625 | 75,081,000 | 0 |
| Operating Income | -69,167,500 | -89,204,498 | -69,167,500 | 0 |
| Interest Expense | 0 | 716,837 | 0 | 0 |
| Income Before Tax | -85,144,500 | -100,706,350 | -85,144,500 | 0 |
| Income Tax Expense | 0 | 0 | 0 | 0 |
| Net Income | -84,782,500 | -99,967,879 | -84,782,500 | 0 |
| Per Share | ||||
| EPS | -0.21 | -0.23 | -0.21 | -0.21 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Statement (Annual) | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Revenue | 88,242,507 | 0 | 0 |
| Cost of Revenue | 21,641,998 | 0 | 0 |
| Gross Profit | 66,600,507 | 0 | 0 |
| Operating Expenses | |||
| R&D Expenses | 0 | 0 | 0 |
| SG&A Expenses | 117,346,257 | 68,183 | 150,309,000 |
| Operating Expenses | 290,601,095 | 210,820 | 421,283,000 |
| Operating Income | -224,000,587 | -210,820 | -438,460,000 |
| Interest Expense | 844,560 | 289,000 | 142,000 |
| Income Before Tax | -265,646,117 | -185,829 | -379,096,000 |
| Income Tax Expense | 0 | 0 | 0 |
| Net Income | -264,209,292 | -177,510 | -371,736,000 |
| Per Share | |||
| EPS | -0.64 | -0.43 | -0.89 |
| EPS Diluted | 0.00 | 0.00 | 0.00 |
| Balance Sheet (Quarterly) | 2024-12-31 | 2023-12-31 |
|---|---|---|
| Assets | ||
| Cash and Cash Equivalents | 605,991,000 | 927,826,000 |
| Short Term Investments | 0 | 166,438,000 |
| Net Receivables | 9,306,000 | 0 |
| Inventory | 35,653,000 | 28,126,000 |
| Total Current Assets | 685,855,000 | 1,154,913,000 |
| Property Plant Equipment | 194,242,000 | 138,549,000 |
| Goodwill and Intangibles | 4,010,000 | 4,140,000 |
| Total Assets | 1,027,565,000 | 1,327,092,000 |
| Liabilities | ||
| Account Payables | 12,097,000 | 16,939,000 |
| Short Term Debt | 18,008,000 | 1,918,000 |
| Total Current Liabilities | 64,201,000 | 58,681,000 |
| Long Term Debt | 46,411,000 | 42,157,000 |
| Total Liabilities | 110,612,000 | 100,838,000 |
| Shareholders Equity | ||
| Retained Earnings | -1,483,421,000 | -1,305,911,000 |
| Total Shareholders Equity | 931,762,000 | 1,232,873,000 |
| Balance Sheet (Annual) | 2024-12-31 | 2023-12-31 |
|---|---|---|
| Assets | ||
| Cash and Cash Equivalents | 605,991,000 | 927,826,000 |
| Short Term Investments | 0 | 166,438,000 |
| Net Receivables | 9,306,000 | 0 |
| Inventory | 35,653,000 | 28,126,000 |
| Total Current Assets | 685,855,000 | 1,154,913,000 |
| Property Plant Equipment | 194,242,000 | 138,549,000 |
| Goodwill and Intangibles | 4,010,000 | 4,140,000 |
| Total Assets | 1,027,565,000 | 1,327,092,000 |
| Liabilities | ||
| Account Payables | 12,097,000 | 16,939,000 |
| Short Term Debt | 18,008,000 | 1,918,000 |
| Total Current Liabilities | 64,201,000 | 58,681,000 |
| Long Term Debt | 46,411,000 | 42,157,000 |
| Total Liabilities | 110,612,000 | 100,838,000 |
| Shareholders Equity | ||
| Retained Earnings | -1,483,421,000 | -1,305,911,000 |
| Total Shareholders Equity | 931,762,000 | 1,232,873,000 |
| Cash Flow Statement (Quarterly) | 2024-12-31 | 2023-12-31 |
|---|---|---|
| Operating Activities | ||
| Net Income | -177,510,000 | -371,736,000 |
| Depreciation & Amortization | 12,844,000 | 12,060,000 |
| Stock Based Compensation | 5,696,000 | 205,388,000 |
| Change in Working Capital | -49,088,000 | -39,528,000 |
| Operating Cash Flow | -217,552,000 | -222,442,000 |
| Investing Activities | ||
| Capital Expenditure | -71,261,000 | -78,630,000 |
| Investments | -71,261,000 | -78,196,000 |
| Investing Cash Flow | 5,593,000 | 358,132,000 |
| Financing Activities | ||
| Debt Repayment | 13,344,000 | 40,746,000 |
| Common Stock Issued/Repurchased | -127,254,000 | 17,853,000 |
| Dividends Paid | 0 | 0 |
| Financing Cash Flow | -110,744,000 | 56,442,000 |
| Summary | ||
| Free Cash Flow | -288,813,000 | -301,072,000 |
| Net Change in Cash | -321,835,000 | 200,462,000 |
| Cash Flow Statement (Annual) | 2024-12-31 | 2023-12-31 |
|---|---|---|
| Operating Activities | ||
| Net Income | -177,510,000 | -371,736,000 |
| Depreciation & Amortization | 12,844,000 | 12,060,000 |
| Stock Based Compensation | 5,696,000 | 205,388,000 |
| Change in Working Capital | -49,088,000 | -39,528,000 |
| Operating Cash Flow | -217,552,000 | -222,442,000 |
| Investing Activities | ||
| Capital Expenditure | -71,261,000 | -78,630,000 |
| Investments | -71,261,000 | -78,196,000 |
| Investing Cash Flow | 5,593,000 | 358,132,000 |
| Financing Activities | ||
| Debt Repayment | 13,344,000 | 40,746,000 |
| Common Stock Issued/Repurchased | -127,254,000 | 17,853,000 |
| Dividends Paid | 0 | 0 |
| Financing Cash Flow | -110,744,000 | 56,442,000 |
| Summary | ||
| Free Cash Flow | -288,813,000 | -301,072,000 |
| Net Change in Cash | -321,835,000 | 200,462,000 |